mutations and complicated kar yotype. It follows a linear evolution with the CLL clone throughout the recurrent acquisition of CDKN2ANot all patients with CLL involve therapy. Irrespective of all latest advances, the iwCLL continue to suggests watchful observation for patients with asymptomatic sickness.86 This suggestion is based on not less than